George Karpouzas, MD (he/him/his)

Harbor-UCLA Medical Center
Torrance, California, United States

Professor of Medicine, David Geffen School of Medicine, UCLA
Chief, Division of Rheumatology, Harbor-UCLA Medical Center
The Lundquist Institute for Medical Innovation

Presentation(s):

• 1331: anti-beta-2-glycoprotein-1 Iga Antibodies Facilitate Macrophage Cholesterol Loading and Influence Coronary Atherosclerosis Progression in a Dose-dependent Manner in Rheumatoid Arthritis

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Janssen: Consultant (Terminated, July 1, 2024); Pfizer: Grant/Research Support (Ongoing); Scipher: Consultant (Terminated, January 31, 2025), Grant/Research Support (Terminated, January 31, 2025)

• 1330: Sex and reproductive stage modify the role of endogenous estrogens on coronary atherosclerosis in rheumatoid arthritis and differences reflect effects on inflammation and cholesterol metabolism

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Janssen: Consultant (Terminated, July 1, 2024); Pfizer: Grant/Research Support (Ongoing); Scipher: Consultant (Terminated, January 31, 2025), Grant/Research Support (Terminated, January 31, 2025)

• 1955: Regional variations in the relationship between pericoronary fat enhancement and atherosclerosis may reflect differences in local vascular inflammation in rheumatoid arthritis

  Tuesday, October 28, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Janssen: Consultant (Terminated, July 1, 2024); Pfizer: Grant/Research Support (Ongoing); Scipher: Consultant (Terminated, January 31, 2025), Grant/Research Support (Terminated, January 31, 2025)